iktos logo

iktos

Artificial intelligence for new drug design

85 employees · est. 2016 · Paris, France

VS
PROTEINA logo

PROTEINA

Our Protein-protein interaction (PPI) analysis platform enables quantitative measurements at the single-molecule level

32 employees · est. 2015 · Seoul, Korea South

PROTEINA is the older company (2016 vs 2015); iktos is the larger of the two.

Side-by-Side Comparison

iktos PROTEINA
Founded
2016 2015 older
Headquarters
Paris, France Seoul, Korea South
Employees
85 larger 32
Industry
AI, Biotechnology, Health Care Biotechnology, Health Care, Life Sciences
Funding Stage
Series A Series C
Total Funding
$18.90M $19.00B
Funding Rounds
7 2
Services
Generative AI Platform (Makya), AI-Driven Retrosynthesis (Spaya), Automated Drug Development Pipeline, Autonomous Lab Robotics Not tracked yet
Target Customers
Pharmaceutical Companies, Biotech Firms, Academic Institutions, Medicinal and Computational Chemists, Drug Discovery Teams Not tracked yet
Taxonomy
Drug Design, Medicinal Chemistry, Generative AI, Chemoinformatics, Robotics Automation, SaaS Software, Molecular Modeling, Oncology, Retrosynthesis, Protein-Protein Interactions, RNA-Protein Interactions, Synthesis Automation, Pharmaceutical R&D, Lead Optimization Protein-protein Interaction, PPI Analysis, Single-molecule Co-immunoprecipitation, Quantitative Measurements, Drug Efficacy Modeling, Protein Analysis, Disease Diagnostics, Drug Discovery, Biotech Startup, Molecular Analysis, Diagnostic Technology, Pharmaceutical Research, Biomedical Innovation
Website
iktos.ai proteina.co.kr
iktos logo

About iktos

Iktos, founded in 2016 and headquartered in France, stands out as a leader in the convergence of AI and biotechnology for drug discovery. Its slogan, "Artificial intelligence for new drug design," encapsulates its mission to leverage cutting-edge technologies for medicinal chemistry. The company's...

PROTEINA logo

About PROTEINA

PROTEINA is a biotechnology startup based in South Korea, founded in 2015. The company has revolutionized protein analysis with its first-in-class protein-protein interaction (PPI) analysis platform, utilizing proprietary 'single-molecule co-immunoprecipitation' technology for quantitative measureme...

We will tell you when either one moves

BounceWatch watches iktos and PROTEINA for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at iktos and PROTEINA — by email.

Frequently Asked Questions

iktos — Artificial intelligence for new drug design. PROTEINA — Our Protein-protein interaction (PPI) analysis platform enables quantitative measurements at the single-molecule level. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
iktos has raised $18.90M while PROTEINA has raised $19.00B.
iktos and PROTEINA operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare iktos with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at iktos on 20 Sep 2026, and PROTEINA on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy